157 related articles for article (PubMed ID: 32847035)
21. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy.
Takahashi H; Mori K; Sekino Y; Okumura T; Hiyama T; Fukuda K; Hasegawa N; Sakai M; Kikuchi S; Takei Y; Iizumi T; Sakurai H; Minami M
J Oncol; 2019; 2019():3580379. PubMed ID: 31354819
[TBL] [Abstract][Full Text] [Related]
22. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma.
Kim TH; Park JW; Kim BH; Kim DY; Moon SH; Kim SS; Lee JH; Woo SM; Koh YH; Lee WJ; Kim CM
Oncotarget; 2018 Jan; 9(3):4034-4043. PubMed ID: 29423102
[TBL] [Abstract][Full Text] [Related]
23. Three cases of hepatocellular carcinoma treated 4 times with proton beams.
Murakami M; Fukumitsu N; Okumura T; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Ishikawa H; Tsuboi K; Sakurai H
Mol Clin Oncol; 2020 Jan; 12(1):31-35. PubMed ID: 31814974
[TBL] [Abstract][Full Text] [Related]
24. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.
Yeh TS; Jan YY; Tseng JH; Chiu CT; Chen TC; Hwang TL; Chen MF
Am J Gastroenterol; 2000 Feb; 95(2):432-40. PubMed ID: 10685746
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma].
Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652
[No Abstract] [Full Text] [Related]
26. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
27. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
[TBL] [Abstract][Full Text] [Related]
28. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients' registration database, Proton-Net.
Yamazaki H; Shibuya K; Kimoto T; Suzuki M; Murakami M; Terashima K; Okimoto T; Iizumi T; Sakurai H; Wakatsuki M; Suzuki O; Katoh N; Arimura T; Ogino T; Takagi M; Araya M; Waki T; Matsumoto S; Ogino H; Fukumoto T; Ohtsuka M
Clin Transl Radiat Oncol; 2023 Jul; 41():100634. PubMed ID: 37234735
[TBL] [Abstract][Full Text] [Related]
29. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
30. Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience.
Mizumoto M; Oshiro Y; Okumura T; Fukumitsu N; Numajiri H; Ohnishi K; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
Int J Part Ther; 2016 Mar; 2(4):570-578. PubMed ID: 31772968
[TBL] [Abstract][Full Text] [Related]
31. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
[TBL] [Abstract][Full Text] [Related]
32. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
33. Proton beam therapy for liver cancers.
Chuong M; Kaiser A; Molitoris J; Mendez Romero A; Apisarnthanarax S
J Gastrointest Oncol; 2020 Feb; 11(1):157-165. PubMed ID: 32175119
[TBL] [Abstract][Full Text] [Related]
34. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
[TBL] [Abstract][Full Text] [Related]
35. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment of a patient with diaphragmatic invasion by a ruptured hepatocellular carcinoma with biliary and portal venous tumor thrombi.
Maruyama H; Yoshida H; Hirakata A; Matsutani T; Yokoyama T; Suzuki S; Matsushita A; Sasajima K; Kikuchi Y; Uchida E
J Nippon Med Sch; 2012; 79(2):147-52. PubMed ID: 22687359
[TBL] [Abstract][Full Text] [Related]
37. Kasai portoenterostomy--new insights from hepatic morphology.
Hussein A; Wyatt J; Guthrie A; Stringer MD
J Pediatr Surg; 2005 Feb; 40(2):322-6. PubMed ID: 15750923
[TBL] [Abstract][Full Text] [Related]
38. Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature.
Lin YL
World J Hepatol; 2018 Oct; 10(10):772-779. PubMed ID: 30386470
[TBL] [Abstract][Full Text] [Related]
39. Proton Beam Therapy in Managing Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Lee CH; Chen AH; Hung SP; Hsieh CE; Tseng JH; Chen PJ; Cheng JY; Chang JT; Chan KM; Lin SM; Lin CC; Chen WT; Chen WY; Huang BS
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406392
[TBL] [Abstract][Full Text] [Related]
40. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
